Heart Matters
Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more.
So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.
16-30 of 265
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Heart MattersHidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Plasma Biomarkers Associated with HF Hospitalization in Atrial Fibrillation
Heart MattersPlasma Biomarkers Associated with HF Hospitalization in Atrial Fibrillation
FAI and the Future of Cardiac Risk Stratification
Heart MattersFAI and the Future of Cardiac Risk Stratification
Redefining ATTR Treatment: Key Mechanisms and Emerging Data
Heart MattersRedefining ATTR Treatment: Key Mechanisms and Emerging Data
Ahmad Masri, MD, MS
Advances in ATTR-CM: Evolving Diagnostics and Therapeutics
Heart MattersAdvances in ATTR-CM: Evolving Diagnostics and Therapeutics
Kevin Alexander
Treating ATTR-CM Early: A Shift From Reactive to Strategic Care
Heart MattersTreating ATTR-CM Early: A Shift From Reactive to Strategic Care
Quan Bui, MD
- advertisement
Advancing Diagnosis of Transthyretin Cardiac Amyloidosis in Underserved Populations
Heart MattersAdvancing Diagnosis of Transthyretin Cardiac Amyloidosis in Underserved Populations
Understanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
Heart MattersUnderstanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
ATTR-CM Trials Revisited: A Broader View of Treatment Benefit
Heart MattersATTR-CM Trials Revisited: A Broader View of Treatment Benefit
Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025
Heart MattersClosing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025
Laurence Sperling, MD
Eugenia Gianos, MD
Finerenone for CKD in Type 1 Diabetes: Updates from FINE-ONE
Heart MattersFinerenone for CKD in Type 1 Diabetes: Updates from FINE-ONE
Janet B. McGill, MD, MA, FACE, FACP
Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
Heart MattersRethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
Susan Davis
- advertisement
Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control
Heart MattersTargeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Heart MattersNavigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Jun-ichi Abe
PREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
Heart MattersPREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
